Receive Email Updates

WASHINGTON BIOTECHNOLOGY, INC.

Now in our 24th Year of Service in Drug Development

 

In Vivo Inflammation Models


Drug & Vaccine Studies Drug Development Support Services Custom Antibodies
Arthritis Models Inflammation Xenograft Studies PK / TOX Rapid-turnaround

 

Inflammation

WBI offers a wide variety of economical, in vivo models to assess efficacy of anti-inflammatory test compounds. Our experienced technical personnel provide quality studies and experienced observations for your full information.

Your study receives our careful attention -

  • A WBI Project Manager assigned to every project.
  • A complete, detailed Protocol and Schedule is prepared for your acceptance before work begins.
  • During your study you will receive timely updates by e-mail on results, observations and schedule status.
  • Your completed Project is fully described in a Final Report including statistical/graphical analysis of results.

 

In Vivo Inflammation and Inflammatory Disease Models

 

o        Collagen-Induced Arthritis (CIA) *

o           Pristane-Induced Arthritis (PIA)

o        Adjuvant-Induced Arthritis (AIA)

o          Ovalbumin-Induced Arthritis

o          Air Pouch Model 

o     Zymosan Air Pouch Model

o       PG-PS 10S Rat Model 

  • Antigen-Induced Arthritis  - measures acute and chronic responses in rabbit; large volumes for tissues and joints.
  • Carrageenan Paw Edema (CPE) - rapid one-day initial screen for anti-inflammatory activity; an inexpensive and reliable model.
  • Mouse Ear Edema  Topical - an excellent measure of topical anti-inflammatory activity
  • Mouse LPS Model - cytokine analysis of LPS-stimulated inflammation
  • Inflammatory Bowel Disease (IBD) - Experimental Inflammatory Bowel Disease in Rodents
  • Streptococcal Cell Wall (SCW) PG-PS 10S Rat Model - a valuable model for assessment of the efficacy of therapeutic and prophylactic compounds on the acute and chronic inflammatory responses, especially for arthritis studies.
  • EAE/Peptide Mouse Models for Multiple Sclerosis (MS) -

o        acute and remitting - PLP139-151 peptide-induced EAE Model in SJL Mice

o        chronic, progressive - MOG35-55 peptide-induced EAE Model in C57BL/6 Mice.

* Collagen-Induced Arthritis (CIA) Sample Graphical Analysis of Results


Click to Enlarge

Click to Enlarge

In Vitro Assays for Anti-inflammatory Efficacy Testing

 

To complement our In Vivo models, Washington Biotechnology offers In Vitro models for early screening of test materials:

 

Whole Blood Assay (WBA) - In Vitro assay measuring cytokine production/inhibition within inflamed whole human blood modeling the environment for actual drug activity

You can choose from additional WBI services to extend analysis of inflammatory effects as may be beneficial for your requirements: Blood samples, cytokines, clinical chemistries, cell counts and differentials, necropsy, organ removals and preservation, histologies.

 

Please contact us for further information and a custom quotation.




Home | About Us | Services | Whats New | Contact Us | Quote | Exhibits | Careers

Copyright Washington Biotechnology Inc., 1999. All Rights Reserved.
Built by Biz-Zone